Wird geladen...
Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for all
Continued research in the treatment of castration-resistant prostate cancer (CRPC) has allowed for a clearer understanding of this disease entity and further treatment advances. In a study recently published by Beer et al.1 in the New England Journal of Medicine, another advance to treatment was dem...
Gespeichert in:
| Veröffentlicht in: | Asian J Androl |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medknow Publications & Media Pvt Ltd
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4236319/ https://ncbi.nlm.nih.gov/pubmed/25155108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.137680 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|